Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuphar Veiga

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 11, 2023
Targeted nanomedicine: Lessons learned and future directionsNuphar Veiga, Yael Diesendruck, Dan Peer
Advanced Drug Delivery Reviews|April 17, 2020
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytesNuphar Veiga, Yael Diesendruck, Dan Peer
Inflammatory Bowel Diseases|February 4, 2016
Colitis ImmunoPET: Defining Target Cell Populations and Optimizing PharmacokineticsJason L J Dearling, Ala Daka, Nuphar Veiga, et al.
Nature Communications|October 31, 2018
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytesNuphar Veiga, Meir Goldsmith, Yasmin Granot, et al.
Nature Nanotechnology|June 18, 2021
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeuticsNiels Dammes, Meir Goldsmith, Srinivas Ramishetti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2019
Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory targetNuphar Veiga, Meir Goldsmith, Yael Diesendruck, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2021
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticlesLiyona Kampel, Meir Goldsmith, Srinivas Ramishetti, et al.
Pharmaceutics|June 11, 2020
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell TransfectionEdo Kon, Inbal Hazan-Halevy, Daniel Rosenblum, et al.
Science Advances|November 19, 2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapyDaniel Rosenblum, Anna Gutkin, Ranit Kedmi, et al.
Nature Nanotechnology|January 31, 2018
A modular platform for targeted RNAi therapeuticsRanit Kedmi, Nuphar Veiga, Srinivas Ramishetti, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 11, 2023
Targeted nanomedicine: Lessons learned and future directionsNuphar Veiga, Yael Diesendruck, Dan Peer
Advanced Drug Delivery Reviews|April 17, 2020
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytesNuphar Veiga, Yael Diesendruck, Dan Peer
Inflammatory Bowel Diseases|February 4, 2016
Colitis ImmunoPET: Defining Target Cell Populations and Optimizing PharmacokineticsJason L J Dearling, Ala Daka, Nuphar Veiga, et al.
Nature Communications|October 31, 2018
Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytesNuphar Veiga, Meir Goldsmith, Yasmin Granot, et al.
Nature Nanotechnology|June 18, 2021
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeuticsNiels Dammes, Meir Goldsmith, Srinivas Ramishetti, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2019
Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory targetNuphar Veiga, Meir Goldsmith, Yael Diesendruck, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2021
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticlesLiyona Kampel, Meir Goldsmith, Srinivas Ramishetti, et al.
Pharmaceutics|June 11, 2020
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell TransfectionEdo Kon, Inbal Hazan-Halevy, Daniel Rosenblum, et al.
Science Advances|November 19, 2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapyDaniel Rosenblum, Anna Gutkin, Ranit Kedmi, et al.
Nature Nanotechnology|January 31, 2018
A modular platform for targeted RNAi therapeuticsRanit Kedmi, Nuphar Veiga, Srinivas Ramishetti, et al.
Pageof 2